Seer Funding & Investors
New York, NY
Seer, Inc. operates as a biotechnology company. The Company offers solutions which combines proprietary engineered nanoparticles with an automated assay solution to provide an unmatched combination of unbiased, deep, rapid, and scalable workflow to give you a clearer view of the proteome. Seer serves customers in the United States.
seer.bioTotal Amount Raised: $186,924,992
Seer Funding Rounds
Series B
$15,000,000
Series B Investors
IDG CapitalSAIF PartnersBroadstream CapitalSeed
$2,300,000
Seed Investors
Foundation CapitalHarvard Management CompanyGlobal Founders CapitalSoftBank GroupPioneer FundEsas VenturesOpen Opportunity FundBlaine VessPre Seed
$125,000
Pre Seed Investors
Y CombinatorAlarko VenturesSeries D
$55,000,000
Series D Investors
FidelityInvusT. Rowe PriceHBM Healthcare InvestmentsaMoon FundMaverick VenturesEmerson CollectiveSolasta VenturesIPO
Unknown
Series D
$55,000,000
Series D Investors
aMoon FundT. Rowe PriceAju IB InvestmentWing Venture ManagementMaverick VenturesInvusEmerson CollectiveSeries C
$17,500,000
Series C Investors
Aju IB InvestmentWing Venture ManagementInvusMaverick VenturesEmerson CollectiveSeries B
$36,000,000
Series B Investors
InvusMaverick VenturesEmerson CollectiveSeries A
$6,000,000
Series A Investors
Maverick Ventures
Funding info provided by Diffbot.